Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medpace Holdings, Inc.MEDP · Entity 3327 | CFO & Treasurer | August 20, 2026 | August 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medpace Holdings, Inc.
Report date August 20, 2026 · Filed August 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,830 |
Ending reported balance
After 2026-08-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-20 · Exercise / conversion · Acquired 3,400 · Balance 16,230 Row 2 · 2026-08-20 · Sale · Disposed 3,400 · Balance 12,830 F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $138.87 · Expires 2027-08-15 | Direct | 3,403 |
Reported balance
After 2026-08-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-20 · Exercise / conversion · Disposed 3,400 · Balance 3,403 F2: The option vested in full on February 15, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
F2: The option vested in full on February 15, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2026 Filed Aug 24, 2026 20:27 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,400 | $0.00 Strike: $138.87 | $0.00 |
DisclosureSEC source: 0000892251-26-000149 · form4.xml · derivative · entry 3 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,403 Underlying: Common Stock · 3,400 shares Expires 2027-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in full on February 15, 2026. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 20:27 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,400 | $625.24 | $2,125,816.00 |
DisclosureSEC source: 0000892251-26-000149 · form4.xml · nonDerivative · entry 2 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,830 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 20:27 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 3,400 | $138.87 | $472,158.00 |
DisclosureSEC source: 0000892251-26-000149 · form4.xml · nonDerivative · entry 1 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 20:42 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001877121-26-000002 · wk-form4_1777408941.xml · derivative · entry 4 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F4 · derivative.exercise_date: The restricted stock units vest in full on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. F4 · derivative.expiration_date: The restricted stock units vest in full on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 20:42 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $410.54 | $0.00 |
DisclosureSEC source: 0001877121-26-000002 · wk-form4_1777408941.xml · derivative · entry 3 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-04-24 F2 · derivative.exercise_date: The option vests on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 20:42 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $138.87 | $0.00 |
DisclosureSEC source: 0001877121-26-000002 · wk-form4_1777408941.xml · derivative · entry 2 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,803 Underlying: Common Stock · 7,000 shares Expires 2027-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in full on February 15, 2026. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 20:42 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 7,000 | $138.87 | $972,090.00 |
DisclosureSEC source: 0001877121-26-000002 · wk-form4_1777408941.xml · nonDerivative · entry 1 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:40 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $166.73 | $0.00 |
DisclosureSEC source: 0001877121-25-000004 · wk-form4_1764106816.xml · derivative · entry 4 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2026-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in full on October 27, 2025. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:40 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GiftCommon Stock | 170 | $0.00 | $0.00 |
DisclosureSEC source: 0001877121-25-000004 · wk-form4_1764106816.xml · nonDerivative · entry 3 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,830 F3 · kind: On November 21, 2025, the Reporting Person gifted 170 shares of common stock to a donor-advised fund. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:40 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,000 | $590.35 | $1,771,050.00 |
DisclosureSEC source: 0001877121-25-000004 · wk-form4_1764106816.xml · nonDerivative · entry 2 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 F1 · kind: The transactions reported on this line were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $590.00 to $590.72. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:40 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 3,000 | $166.73 | $500,190.00 |
DisclosureSEC source: 0001877121-25-000004 · wk-form4_1764106816.xml · nonDerivative · entry 1 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 21:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $57.94 | $0.00 |
DisclosureSEC source: 0001668397-25-000093 · wk-form4_1753736896.xml · derivative · entry 3 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2025-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in full on November 12, 2022. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 21:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 12,000 | $454.23 | $5,450,760.00 |
DisclosureSEC source: 0001668397-25-000093 · wk-form4_1753736896.xml · nonDerivative · entry 2 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $449.25 to $461.24. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 21:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 12,000 | $57.94 | $695,280.00 |
DisclosureSEC source: 0001668397-25-000093 · wk-form4_1753736896.xml · nonDerivative · entry 1 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 6,591 | $0.00 Strike: $325.73 | $0.00 |
DisclosureSEC source: 0001668397-25-000023 · wk-form4_1741641071.xml · derivative · entry 2 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,591 Underlying: Common Stock · 6,591 shares Expires 2032-03-06 F1 · derivative.exercise_date: The option vests on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:18 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000149 · wk-form4_1723061915.xml · derivative · entry 2 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the fifth anniversary of the grant date or August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. F2 · derivative.expiration_date: The restricted stock units vest in full on the fifth anniversary of the grant date or August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $90.65 | $0.00 |
DisclosureSEC source: 0000892251-23-000093 · form4.xml · derivative · entry 3 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in full on August 5, 2019. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 7,000 | $255.00 | $1,785,000.00 |
DisclosureSEC source: 0000892251-23-000093 · form4.xml · nonDerivative · entry 2 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 F1 · shares: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 10,000 | $90.65 | $906,500.00 |
DisclosureSEC source: 0000892251-23-000093 · form4.xml · nonDerivative · entry 1 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 21:48 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-003517 · doc1.xml · derivative · entry 2 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. F2 · derivative.expiration_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 21:21 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 344 | $227.09 | $78,118.96 |
DisclosureSEC source: 0001567619-22-020559 · doc1.xml · nonDerivative · entry 2 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:21 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 1,656 | $229.30 | $379,720.80 |
DisclosureSEC source: 0001567619-22-020559 · doc1.xml · nonDerivative · entry 1 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,344 F1 · shares: Represents shares sold to satisfy tax withholding obligations upon the vesting of restricted stock units previously granted to the Reporting Person. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:13 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 13,803 | $0.00 Strike: $138.87 | $0.00 |
DisclosureSEC source: 0001567619-22-004866 · doc1.xml · derivative · entry 2 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,803 Underlying: Common Stock · 13,803 shares Expires 2027-08-15 F1 · derivative.exercise_date: The option vests on the fourth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,250 | $0.00 Strike: $90.65 | $0.00 |
DisclosureSEC source: 0001567619-21-019332 · doc1.xml · derivative · entry 3 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 1,250 shares Expires 2024-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each option vested on August 5, 2019. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 1,250 | $226.50 | $283,125.00 |
DisclosureSEC source: 0001567619-21-019332 · doc1.xml · nonDerivative · entry 2 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 1,250 | $90.65 | $113,312.50 |
DisclosureSEC source: 0001567619-21-019332 · doc1.xml · nonDerivative · entry 1 Brady Kevin M. · CIK 0001877121 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.